证券代码：688158 证券简称：优刻得 公告编号：2025-031 优刻得科技股份有限公司 关于乌兰察布募投项目进展及业绩完成情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 优刻得科技股份有限公司（以下简称"公司"）于 2020 年 1 月 20 日在上海 证券交易所科创板上市。其中 IPO 募投项目之一为内蒙古乌兰察布市集宁区优 刻得数据中心项目（一期和二期）（以下简称"乌兰察布募投项目"），项目进展 情况已在 2024 年公司年报中披露，现将乌兰察布募投项目建设进展及 2020- 2024 年度业绩经审核的业绩完成情况具体说明如下： 一、项目进展 内蒙古乌兰察布市集宁区优刻得数据中心整体规划用地面积约 140,000 平 方米，建筑面积 107,200 平方米，规划建设 5 栋数据中心，分五期建设，合计 可以容纳 6,000 个机柜。其中 1-4 年建设第一期和第二期，合计容纳 2,600 个机 柜，对应乌兰察布募投项目，该项目投资金额为 149,366.52 万元，拟投入募集 资金 100,956.27 ...

证券代码：688158 证券简称：优刻得 公告编号：2025-033 优刻得科技股份有限公司 关于公司股东协议转让部分股份暨权益变动 的提示性公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 优刻得科技股份有限公司（以下简称"公司"或"标的公司"）的控股股 东、实际控制人莫显峰先生、华琨先生（以下简称"转让方"）与上海太盈私募 基金管理有限公司（代表"太盈开阳一号私募证券投资基金"）（以下简称"太盈 开阳一号"或"受让方"）近期签署了《股票转让协议》，转让方拟向受让方转让 其所持标的公司股票合计 23,428,536 股（占公司总股本的 5.13%），其中华琨先 生转让其持有的公司股票 11,714,268 股股份（占公司总股份的 2.57%）、莫显峰 先生转让其持有的公司股票 11,714,268 股股份（占公司总股份的 2.57%）。受让 方按本协议的约定，合计受让转让方持有的标的公司 23,428,536 股无限售流通 股。受让方承诺在标的股份过户登记完成后 12 个月内不对外减持标的股份。 ...

Core Viewpoint - UCloud's stock price has shown significant growth this year, with an 80.62% increase year-to-date, indicating strong market performance and investor interest [1][2]. Company Overview - UCloud Technology Co., Ltd. is located in Yangpu District, Shanghai, and was established on March 16, 2012, with its IPO on January 20, 2020 [2]. - The company operates as a neutral third-party cloud computing service provider, focusing on creating a secure and reliable cloud computing platform for clients [2]. - Revenue composition includes: Public Cloud 50.63%, Hybrid Cloud 35.41%, Cloud Communication 8.26%, Private Cloud 2.75%, Solutions and Others 1.90%, Edge Cloud 1.05% [2]. - UCloud is categorized under the computer-IT services sector and is involved in various concept sectors such as online education, AI training, and commercial aerospace [2]. Financial Performance - For the first half of 2025, UCloud reported revenue of 791 million yuan, reflecting a year-on-year growth of 8.37%, while the net profit attributable to shareholders was -79.65 million yuan, showing a year-on-year increase of 26.56% [2]. - The company has distributed a total of 21.13 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Shareholder Information - As of June 30, 2025, UCloud had 40,200 shareholders, a decrease of 2.53% from the previous period, with an average of 10,083 circulating shares per shareholder, an increase of 3.42% [2]. - The top ten circulating shareholders include notable funds, with the largest being the Bosera CSI Star Market Artificial Intelligence ETF, holding 3.66 million shares, an increase of 1.34 million shares from the previous period [3].

中国经济网北京9月9日讯 优刻得(688158.SH)今日收报24.21元，跌幅2.89%。目前该股处于破发状 态。 优刻得于2020年1月20日在上交所科创板上市，发行价格为33.23元/股。优刻得上市发行股份数量 为5850万股，保荐人（主承销商）为中国国际金融股份有限公司，保荐代表人为曹宇、樊友彪。 优刻得首次公开发行募集资金总额为19.44亿元，扣除发行费用后，募集资金净额为18.40亿元，分 别多媒体云平台项目、网络环境下应用数据安全流通平台项目、新一代人工智能服务平台项目和内蒙古 乌兰察布市集宁区优刻得数据中心项目（一期和二期）。 优刻得IPO及定增合计募资26.44亿元。 （责任编辑：华青剑） 优刻得的发行费用总计1.04亿元，其中承销费及保荐费8831.31万元。 在跟投方面，中金公司的全资子公司中国中金财富证券有限公司获配股票数量180.56万股，获配金 额6000.00万元，占首次公开发行股票数量的比例3.09%，本次获得配售股票的限售期限为自本次公开发 行的股票在上交所上市之日起24个月。 2022年2月16日，优刻得发布2020年度向特定对象发行股票发行结果暨股本变动公告显示，本次发 ...

Core Viewpoint - The announcement details the results of the stock incentive plan for the first category of incentive objects' fourth vesting period and the second category's third vesting period, highlighting the failure of certain stocks to vest due to performance targets not being met and the departure of some incentive objects [1][8][9]. Group 1: Stock Incentive Plan Overview - The stock incentive plan was approved during the board meeting on May 28, 2020, and subsequently ratified by the shareholders on June 19, 2020 [1][3]. - The plan included a public notice period from June 1 to June 11, 2020, during which no objections were raised regarding the incentive objects [2]. Group 2: Vesting Results - For the first category of incentive objects, 38.825 thousand shares failed to vest due to 11 individuals leaving the company and the company's failure to meet the performance targets for the fourth vesting period [7][8]. - For the second category of incentive objects, 14.6025 thousand shares failed to vest due to one individual leaving and not meeting the performance targets for the third vesting period [8][9]. Group 3: Impact of Non-Vesting - The non-vesting of these shares is not expected to materially impact the company's financial status or operational results, nor will it affect the stability of the core management team [9].

四个归属期及第二类激励对象第三个归属期 行使权益的结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 优刻得科技股份有限公司（以下简称"公司"）于 2020 年 5 月 28 日召开了 第一届董事会第十二次会议和第一届监事会第五次会议，于 2020 年 6 月 19 日召 开股东大会审议通过了《关于<优刻得 2020 年限制性股票激励计划（草案）>及 摘要的议案》等相关议案，现将有关事项及执行情况公告如下： 一、本次股权激励计划已履行的相关决策程序 （一）2020 年 5 月 28 日，公司召开第一届董事会第十二次会议，审议通过 了《关于<优刻得 2020 年限制性股票激励计划（草案）>及摘要的议案》、《关于 <优刻得 2020 年限制性股票激励计划实施考核管理办法>的议案》及《关于提请 股东大会授权董事会办理公司 2020 年限制性股票激励计划有关事项的议案》等 议案。独立董事对此发表了同意的独立意见。以上情况，详见公司于上海证券交 易所网站（www.sse.com.cn）披露的《第一届董事会第十二次会议决议公告》 ...

Group 1 - The Shanghai Stock Exchange recently hosted the sixth Future Industry Salon themed "Brain-Computer Interface: Exploring the Digital Intelligence Era," attended by six listed companies and twelve companies from the brain-computer interface industry chain, along with twelve financial institutions [1] - Brain-computer interfaces (BCIs) create information channels between the brain and external devices, enabling direct information exchange, and are categorized into invasive and non-invasive technology routes [1] - The potential market space for BCIs is estimated to exceed 100 billion USD, with applications spanning healthcare, education, consumer products, and intelligent driving [1] Group 2 - In the healthcare sector, BCIs have already gained traction, supported by an integrated model of industry, academia, and research, with several Sci-Tech Innovation Board listed companies actively investing in the BCI field [1] - Xiangyu Medical has established a brain science laboratory and is collaborating with multiple universities and hospitals, having obtained registration certificates for two brainwave acquisition devices [2] - Youke Technology is providing intelligent computing support to Brain Tiger Technology to advance the application of BCI products in the treatment of patients with aphasia [2]

Core Viewpoint - UCloud Technology Co., Ltd. is hosting a collective performance briefing for the artificial intelligence industry on September 9, 2025, to discuss its 2025 semi-annual financial results and address investor inquiries [1]. Group 1: Meeting Details - The meeting is scheduled for September 9, 2025, from 15:00 to 17:00 [1]. - It will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [1]. - The format of the meeting will be an interactive text-based session [1]. Group 2: Participation Information - Investors can submit questions from September 2 to September 8, 2025, before 16:00 [1]. - Participation in the meeting can be done online through the Shanghai Stock Exchange Roadshow Center [1]. - The company will respond to commonly asked questions during the briefing [1]. Group 3: Attendees - Key attendees include the Chairman and CEO, Mr. Ji Xinhua, the CFO, Mr. Gui Shuifa, and the Secretary of the Board, Mr. Xu Hongjie [1]. - There may be adjustments to the attendees based on special circumstances [1]. Group 4: Contact Information - For inquiries, investors can contact the Board Office at 021-55509888-8188 or via email at ir@ucloud.cn [1].

证券代码：688158 证券简称：优刻得 公告编号：2025-029 优刻得科技股份有限公司 关于参加 2025 年半年度科创板人工智能行业 集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 09 月 09 日 （星期二） 15:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/ ） 会 议 召 开 方 式 ： 上 证 路 演 中 心 网 络 文 字 互 动 投资者可于 2025 年 09 月 02 日 （星期二） 至 09 月 08 日 （星期 一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目 或通过公司投资者关系邮箱（ir@ucloud.cn）进行提问。公司将在 说明会上对投资者普遍关注的问题进行回答。 优刻得科技股份有限公司（以下简称"公司"）已于 2025 年 8 月 16 日发布公司 2025 年半年度报告，为便于广大 ...

Core Insights - The food and beverage industry maintains the highest gross margin at 51.41% in the first half of the year, excluding the financial sector [1] - The beauty and personal care, as well as the media industries, rank second and third in gross margin [1] - The pharmaceutical and computer sectors dominate individual stock performance, with the top five companies by gross margin being Hai Chuang Pharmaceutical-U, Ailis, Dameng Data, Dize Pharmaceutical-U, and Zhongwang Software [1] - Hai Chuang Pharmaceutical-U leads with an impressive gross margin of 99.52%, while 27 companies reported gross margins exceeding 90% in the first half of the year [1]